CervoMed Inc.
CRVO
$4.20
-$0.04-0.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -97.30% | -81.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -97.30% | -81.65% | |||
| Cost of Revenue | -3.48% | 18.24% | |||
| Gross Profit | -1.81% | -70.64% | |||
| SG&A Expenses | 7.90% | -28.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.32% | -0.09% | |||
| Operating Income | -3.57% | -21.58% | |||
| Income Before Tax | -4.67% | -23.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.67% | -23.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.67% | -23.46% | |||
| EBIT | -3.57% | -21.58% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -4.63% | -19.44% | |||
| Normalized Basic EPS | -4.64% | -19.43% | |||
| EPS Diluted | -4.63% | -19.44% | |||
| Normalized Diluted EPS | -4.64% | -19.43% | |||
| Average Basic Shares Outstanding | 0.02% | 3.38% | |||
| Average Diluted Shares Outstanding | 0.02% | 3.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||